127 related articles for article (PubMed ID: 34752602)
21. Discrepancies Between Biopsy Gleason Score and Radical Prostatectomy Specimen Gleason Score: An Iranian Experience.
Dolatkhah S; Mirtalebi M; Daneshpajouhnejad P; Barahimi A; Mazdak H; Izadpanahi MH; Mohammadi M; Taheri D
Urol J; 2019 Feb; 16(1):56-61. PubMed ID: 30345499
[TBL] [Abstract][Full Text] [Related]
22. Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
Bell PD; Teramoto Y; Gurung PMS; Yang Z; Miyamoto H
Arch Pathol Lab Med; 2022 Apr; 146(4):469-477. PubMed ID: 35020802
[TBL] [Abstract][Full Text] [Related]
23. Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens.
Swanson GP; Epstein JI; Ha CS; Kryvenko ON
Prostate; 2015 Mar; 75(4):424-9. PubMed ID: 25417762
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
[TBL] [Abstract][Full Text] [Related]
25. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
[TBL] [Abstract][Full Text] [Related]
26. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
Pierorazio PM; Ross AE; Lin BM; Epstein JI; Han M; Walsh PC; Partin AW; Pavlovich CP; Schaeffer EM
BJU Int; 2012 Oct; 110(8):1122-8. PubMed ID: 22373045
[TBL] [Abstract][Full Text] [Related]
27. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
[TBL] [Abstract][Full Text] [Related]
28. Downgrading of biopsy based Gleason score in prostatectomy specimens.
Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
[TBL] [Abstract][Full Text] [Related]
29. Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule.
Vau N; Henriques V; Cheng L; Blanca A; Fonseca J; Montironi R; Cimadamore A; Lopez-Beltran A
Hum Pathol; 2019 Nov; 93():6-15. PubMed ID: 31442520
[TBL] [Abstract][Full Text] [Related]
30. Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted Biopsies.
Deng FM; Isaila B; Jones D; Ren Q; Kyung P; Hoskoppal D; Huang H; Mirsadraei L; Xia Y; Melamed J
Am J Surg Pathol; 2022 Jan; 46(1):44-50. PubMed ID: 34115670
[TBL] [Abstract][Full Text] [Related]
31. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
[TBL] [Abstract][Full Text] [Related]
32. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
[TBL] [Abstract][Full Text] [Related]
33. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
Epstein JI; Feng Z; Trock BJ; Pierorazio PM
Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
[TBL] [Abstract][Full Text] [Related]
34. Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy.
Trpkov K; Sangkhamanon S; Yilmaz A; Medlicott SAC; Donnelly B; Gotto G; Shea-Budgell M
Am J Surg Pathol; 2018 Nov; 42(11):1522-1529. PubMed ID: 30080706
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
[TBL] [Abstract][Full Text] [Related]
36. Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.
Pereira RA; Costa RS; Muglia VF; Silva FF; Lajes JS; Dos Reis RB; Silva GE
Asian J Androl; 2015; 17(5):815-20. PubMed ID: 25652629
[TBL] [Abstract][Full Text] [Related]
37. Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.
Scott S; Samaratunga H; Chabert C; Breckenridge M; Gianduzzo T
BJU Int; 2015 Oct; 116 Suppl 3():26-30. PubMed ID: 26260531
[TBL] [Abstract][Full Text] [Related]
38. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
39. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
40. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Trabulsi EJ; Lallas CD; Fleshner NE; Tilki D; Chandrasekar T
Urology; 2020 Mar; 137():102-107. PubMed ID: 31705947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
